Society of Nuclear Medicine and Molecular Imaging

The rise of theranostics: Part 7 -- Nuclear medicine technologists' rapid evolution As theranostics gains speed, nuclear medicine technologists (NMTs) face a defining moment.

@auntminnie.bsky.social covers how the rise of radiopharmaceuticals and theranostics creates more opportunities for nuclear medicine technologists. Read here: www.auntminnie.com/clinical-new...

Read the full article in JNM here: jnm.snmjournals.org/content/earl...

The imaging patterns identified on PET and MRI in this study provide clinicians with a practical tool to detect potential LATE pathology in patients with cognitive impairment and to inform clinical management and future investigations of LATE.

Commonly-available imaging tests, such as PET, MRI, and clinical assessment, identified LATE. 3D-SSP PET templates were made from a dataset of autopsy-confirmed datasets of both LATE and Alzheimer’s Disease patients.

944 18F-FDG PET cases were analyzed using z-score maps.

Cognitive decline may look the same on the outside, but the biology of limbic-predominant age-related TDP-43 encephalopathy (LATE) vs. Alzheimer’s is notoriously hard to diagnose. In JNM, researchers use a novel PET/MRI approach to identify LATE: jnm.snmjournals.org/content/earl...

YouTube video by Society of Nuclear Medicine and Molecular Imaging Not Another Pizza Party: Facing Burnout in Nuclear Medicine

Do pizza Fridays actually combat burnout? Probably not! On this episode of the JNMT Podcast, host Jessica Settle is joined by Jamie Warren, a technologist and career coach who shares her insights about identifying, managing, and overcoming burnout. Listen here: youtu.be/wH-KohjGgAE?...

Ken Herrmann to be Next Editor-in-Chief of The Journal of Nuclear Medicine

You may recognize Ken from the many episodes of the JNM Podcast he's hosted. As editor, Ken hopes to keep that engagement going -- and more!

Learn more here: snmmi.org/Web/News/Art...

Public awareness doesn’t grow on its own, it takes a collective voice. When you’re an SNMMI-TS member, you're ensuring NMTs are recognized for their expertise. Join SNMMI or renew your membership & explore how we support you, beyond VOICE credits. snmmi.org/Shared_Conte...

Dual PET approach for personalized head and neck cancer treatment Novel imaging strategy could push tumor control rates from 60% to over 90%

Beyond "one-size-fits-all": A new strategy that combines two types of #PET scans can guide personalized #radiotherapy for head and neck cancers, according to new research led by 🇸🇪 @stockholm-uni.bsky.social, published by @snm-mi.bsky.social. #HeadAndNeckCancer #PersonalizedMedicine

For example, Lee will go over A.R.E.: Appreciation, Recognition and Encouragement. Join us to learn from Lee Cockerell how to accomplish the hard conversations and hard decisions as they appear in your life.

Drawing from his life experience, Lee will also discuss time management and how to handle pressure and anxiety, helping keep your life under control. Joining this webinar will help you effectively learn the difference between management and leadership and how to execute both in your role.

You will learn the concept of Hire Them Right, Train Them Right, and Treat Them Right as well as the Four Customer Expectations and The Four Employee Expectations. Throughout his discussion on competency, Lee will talk about the importance of education, experience, exposure, and clarity.

Lee Cockerell retired as the Executive Vice President of Operations for the Walt Disney World® Resort. Focusing on the internal team and customers, Lee will discuss how to become a better leader and manager.

SNMMI-TS Webinar: YOU Can Create Disney Magic Too... Lessons in Leadership, Management, Culture and World Class Customer Service

Register here: events.teams.microsoft.com/event/0a5ee0...

Attendees will gain a greater understanding of the financial requirements for starting and sustaining a theranostics program.

The primary audience includes nuclear medicine physicians and technologists, radiologists, and healthcare administrators in community practices. The goal is to share practical knowledge on the reimbursement landscape so community centers can improve patient access to these advanced treatments.

SNMMI CBNM Webinar: Wednesday, January 28 at 12:00 pm ET This webinar provides an introductory, high-level overview of the financial and billing requirements, emphasizing coding, billing, and payment rates. The goal is to share practical knowledge on the reimbursement landscape so community centers can improve patient access to these advanced treatments. Attendees will gain a greater understanding of the financial requirements for starting and sustaining a theranostics program.

SNMMI CBNM Webinar: Wednesday, January 28 at 12:00 pm ET

This webinar provides an introductory, high-level overview of the financial and billing requirements, emphasizing coding, billing, and payment rates.

Register here: snmmi.org/iCore/Events...

More Americans are surviving cancer — even the deadliest ones For the first time, the five-year survival rate for all cancers has reached 70 percent, according to a new report from the American Cancer Society.

70% of all cancer patients are now living past the 5-year survival mark -- the highest percentage ever. Advancements in nuclear medicine - particularly in theranostics - are driving this dramatic improvement in patient outcomes.

Read more: www.washingtonpost.com/health/2026/...

Journal of Nuclear Medicine: 67 (1)

Read the full issue of the January 2026 edition of JNM here: jnm.snmjournals.org/content/67/1

YouTube video by Society of Nuclear Medicine and Molecular Imaging JNM Podcast Episode 15: 2025: A Year in Review

BONUS! 🎙️JNM Podcast Episode 15: 2025: A Year in Review

youtu.be/Kxibmu8tRaE?...

YouTube video by Society of Nuclear Medicine and Molecular Imaging JNM Podcast Episode 14: SPARC: Overarching Framework for PSMA PET Reporting

🎙️JNM Podcast Episode 14: SPARC: Overarching Framework for PSMA PET Reporting

youtu.be/MOkGjJtKJY0?...

💡FEATURED: Claudin 18.2 as a Biomarker for Imaging and Radiopharmaceutical Therapy in Gastric and Pancreatic Tumors

jnm.snmjournals.org/content/67/1...

💡FEATURED: Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial

jnm.snmjournals.org/content/67/1...

💡FEATURED: 68Ga-FAPI-04 PET for Detecting Occult Peritoneal Metastasis in Locally Advanced Gastric Cancer: Diagnostic Performance and Cost Analyses in a Single-Center, Prospective Cohort Study

jnm.snmjournals.org/content/67/1...

🔥Hot Topics: Liquid Biopsy of Circulating Tumor Cells and DNA in the Context of PSMA Radiopharmaceutical Therapy

jnm.snmjournals.org/content/67/1...

⚙️The State of the Art: Rechallenge and Extended [177Lu]Lu-PSMA Therapy in Metastatic Prostate Cancer

jnm.snmjournals.org/content/67/1/4

💬Discussions with Leaders: Making a Career to Fight Cancer

jnm.snmjournals.org/content/67/1/1

New year, new JNM! If you have a resolution to read more scientific articles, good news: the new issue of JNM is out now. Take a look at the highlights 👇🧵

YouTube video by Society of Nuclear Medicine and Molecular Imaging JNM Podcast Episode 15: 2025: A Year in Review

According to one of our guests, 2025 was the biggest year in nuclear medicine...yet. Before we pop the champagne and ring in 2026, join us for one last 2025 episode of the JNM Podcast, where our guests share their highlights for the year. Tune in wherever you stream podcasts! youtu.be/Kxibmu8tRaE

GUEST Three world-leading nuclear medicine organizations—the SNMMI Clinical Trials Network (SNMMI-CTN), the Australasian Radiopharmaceutical Trials Network (ARTnet), and the European Association of Nuclear ...

The SNMMI-CTN joins ARTnet and EARL in endorsing a unified PET/CT and PET/MR scanner accreditation framework to standardize and harmonize quantitative PET imaging worldwide. Read more about this landmark effort here: